Resources
9 Results (showing 1 - 9)
Results sorted by posted date (oldest first)
Results sorted by posted date (oldest first)
Posted 1/28/2020 (updated 3/28/2024)
In January 2014, the American Society of Addiction Medicine (ASAM) released its Standards of Care for the Addiction Specialist Physician.
Posted 5/5/2020 (updated 3/28/2024)
This was the first session in the telehealth series. There were various speakers and panelists from agencies including JBS International, Global Partnership for Telehealth, H.O.P.E. Telehealth Consortium, HRSA’s Office for the Advancement of Telehealth, and the Telehealth Resource Centers.
Posted 5/13/2020 (updated 3/28/2024)
This was the second session in the telehealth series. There were various speakers and panelists from agencies including JBS International, Global Partnership for Telehealth, H.O.P.E. Telehealth Consortium, HRSA’s Office for the Advancement of Telehealth, and the Telehealth Resource Centers.
Posted 7/27/2020 (updated 3/28/2024)
The American Medical Association’s Opioid Task Force report shows a dramatic increase in fatalities involving illicit opioids, stimulants (e.g. methamphetamine), heroin and cocaine and a similarly dramatic drop in the use of prescription opioids.
Posted 9/4/2020 (updated 3/29/2024)
The analysis examined syndromic surveillance data from 2018–2019 in 29 states for suspected nonfatal drug and polydrug overdoses treated in emergency departments.
Posted 10/21/2020 (updated 4/3/2024)
This study sought to identify best practices for retaining individuals in treatment and for achieving continuity of care between settings.
Posted 10/5/2021 (updated 4/3/2024)
This webinar focused on the crucial role of the emergency department (ED) in recognizing and treating opioid use disorder (OUD) patients with evidence-based medications for addiction treatment. Gail D’Onofrio, MD, discussed her pioneering work in creating the evidence for initiating ED buprenorphine treatment with ED patients presenting with opioid use disorder. Overall, the opioid epidemic intertwined with the COVID-19 pandemic has greatly escalated the need to mitigate the morbidity and mortality associated with the rising rate of fentanyl use. Data supporting the use of buprenorphine in the ED setting as well as the consequences of not initiating treatment will be discussed. While the use of ED prescribed buprenorphine has increased, universal adoption has lagged. Barriers to implementation of ED buprenorphine were discussed as well as strategies to overcome these challenges. Components of successful integration of an ED program with community partnerships was outlined. Current research by emergency physicians regarding innovative strategies such as high-dose buprenorphine inductions and use of extended release 7-day formulation of buprenorphine will be discussed. Initiation buprenorphine effectively, reduces withdrawal symptoms, improves adherence to treatment, and saves lives.
Posted 2/28/2023 (updated 3/27/2024)
Researchers looked at records for 917 patients who engaged with a peer recovery coach via telehealth after discharge from emergency departments for opioid use. The investigation focused on one Indiana-based hospital system that included six hospitals located in cities and seven that had rural Critical Access Hospital designations.
Posted 12/1/2023 (updated 3/28/2024)
This publication highlights the Coordinated Opioid Recovery (CORE) Program in three Florida counties. The program integrates a new facet of Emergency Medical Services known as community paramedics. Since its launch in 2022 in Palm Beach County, Florida, CORE has expanded to include 12 additional Florida counties and takes a coordinated approach to recovery for individuals with SUD.